Morning Overview on MSN
New drugs target senescent "zombie" cells, opening a cancer pathway
Chemotherapy kills cancer cells, but it also leaves behind something troubling: damaged cells that stop dividing yet refuse ...
Rushika M. Perera, the Deborah Cowan Professor and vice chair of the Department of Anatomy, and chief scientific officer of ...
3d
Dual-pathway blockade therapy offers hope for rare, hard-to-treat gynecological clear cell cancers
Before her cancer diagnosis in early 2017, 48-year-old Caitlin Delaney, who is based in Australia, had been struggling with a ...
EVANSVILLE, Ind. (WEHT) — A local nonprofit supporting those impacted by cancer is being recognized while also expanding its reach in the community. Cancer Pathways Midwest has been named the March ...
Panakeia (“the Company”), the world’s first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...
A Phase 3 trial found daraxonrasib nearly doubled survival in advanced pancreatic cancer, offering new hope ahead of FDA ...
At AACR 2026, prominent cancer researchers discussed the latest advances in mitigating tumor evasion, targeting cancer ...
Scientists assumed that one specific immune cell subtype was required for mRNA vaccination to activate the immune system. But ...
An experimental drug targeting triple-negative breast cancer overwhelms cancer cells with toxic fats, according to new tests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results